Snapshot from Aug 20, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Encube Ethicals files Rs 3,000 crore IPO
Business IPO filing

Encube Ethicals files Rs 3,000 crore IPO

Analysis based on 7 articles · First reported Aug 03, 2026 · Last updated Aug 03, 2026

Sentiment
60
Attention
4
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The IPO filing signals a potential new listing in the Indian pharmaceutical sector, which could attract investor interest and provide liquidity to existing shareholders. The offer-for-sale structure means no fresh capital for the company, but the listing may enhance its visibility and valuation.

Pharmaceuticals Investment Banking
Event Summary

Encube Ethicals, a Mumbai-based specialty pharmaceutical company, filed its Draft Red Herring Prospectus (DRHP) with the India — Securities and Exchange Board of India (SEBI) on August 3, 2026, for an initial public offering (IPO) valued at Rs 3,000 crore. The IPO is a complete offer for sale by promoter Mehul Madhusudan Shah and investor selling shareholder Frontier Holdings Limited, meaning the company will not receive any proceeds. The company, founded in 1995, specializes in topical and transdermal dosage forms and serves 50 countries, including regulated markets such as the United States, UK, Europe, and India. It reported revenue of Rs 1,848.7 crore and net profit of Rs 436.7 crore in FY26. The book running lead managers are JM Financial, Axis Capital Holdings, and Kotak Mahindra Bank — Kotak Mahindra Capital Company, with MUFG Intime India as registrar. The shares are proposed to be listed on the Bombay Stock Exchange and National Stock Exchange of India.

Key Actions
100 Encube Ethicals filed DRHP India — Securities and Exchange Board of India
80 Mehul Madhusudan Shah offered shares
80 Frontier Holdings Limited offered shares
30 JM Financial appointed lead manager Encube Ethicals
30 Axis Capital Holdings appointed lead manager Encube Ethicals
30 Kotak Mahindra Bank — Kotak Mahindra Capital Company appointed lead manager Encube Ethicals
20 MUFG Intime India appointed registrar Encube Ethicals
Entities Involved
priv
Encube Ethicals
The company is the issuer of the IPO, though it will not receive proceeds as it is an offer for sale. The filing marks a step toward public listing, potentially increasing its profile and access to capital markets.
Importance 100.0 Sentiment 70.0
per
Mehul Madhusudan Shah
As the promoter, he is selling shares in the offer for sale, potentially realizing gains from his stake in the company.
Importance 90.0 Sentiment 70.0
govactor
India — Securities and Exchange Board of India
As the regulator, SEBI received the DRHP and will review the IPO application, playing a key role in the approval process.
Importance 80.0 Sentiment 0.0
priv
Frontier Holdings Limited
As an investor selling shareholder, it is offering shares in the IPO, providing an exit opportunity.
Importance 80.0 Sentiment 70.0
stock
JM Financial
Acting as a book running lead manager, it will earn fees from managing the IPO, benefiting from the transaction.
Importance 60.0 Sentiment 10.0
stock
Axis Capital Holdings
Acting as a book running lead manager, it will earn fees from managing the IPO, benefiting from the transaction.
Importance 60.0 Sentiment 10.0
subs
Kotak Mahindra Bank — Kotak Mahindra Capital Company
Acting as a book running lead manager, it will earn fees from managing the IPO, benefiting from the transaction.
Importance 60.0 Sentiment 10.0
exch
Bombay Stock Exchange
The company plans to list its shares on the BSE, which will see new listing activity.
Importance 50.0 Sentiment 5.0
exch
National Stock Exchange of India
The company plans to list its shares on the NSE, which will see new listing activity.
Importance 50.0 Sentiment 5.0
cnt
India
India is the home market and listing destination, with the IPO subject to Indian regulations and investor interest.
Importance 40.0 Sentiment 10.0
priv
MUFG Intime India
As registrar to the issue, it will handle share allotment and related administrative tasks, earning fees.
Importance 40.0 Sentiment 5.0
cnt
United States
The US is a key regulated market for Encube Ethicals, contributing to its revenue and regulatory accreditations.
Importance 30.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
The USFDA accreditation is a key regulatory approval for the company, enabling access to the US market.
Importance 30.0 Sentiment 0.0
cnt
Japan
Japan's PMDA accreditation is among the regulatory approvals held by the company, supporting its market access.
Importance 20.0 Sentiment 0.0
cnt
United Kingdom
The UK is one of the regulated markets served by the company, part of its global footprint.
Importance 20.0 Sentiment 0.0
+ 3 more entities View on Dashboard
Relationships
India — Securities and Exchange Board of India related ↔ JM Financial
India — Securities and Exchange Board of India related ↔ Axis Capital Holdings
India — Securities and Exchange Board of India related ↔ Kotak Mahindra Bank — Kotak Mahindra Capital Company
India — Securities and Exchange Board of India related ↔ Bombay Stock Exchange
India — Securities and Exchange Board of India related ↔ National Stock Exchange of India
India — Securities and Exchange Board of India related ↔ India
JM Financial related ↔ Axis Capital Holdings
JM Financial related ↔ Kotak Mahindra Bank — Kotak Mahindra Capital Company
JM Financial related ↔ Bombay Stock Exchange
JM Financial related ↔ National Stock Exchange of India
JM Financial related ↔ India
Axis Capital Holdings related ↔ Kotak Mahindra Bank — Kotak Mahindra Capital Company
Axis Capital Holdings related ↔ Bombay Stock Exchange
Axis Capital Holdings related ↔ National Stock Exchange of India
Axis Capital Holdings related ↔ India
+ 6 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.